Peavine Capital, LLC Abb Vie Inc. Transaction History

Peavine Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $230,651 - $293,232	-1,676 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $180,052 - $227,818	1,676 New	1,676 $227,000
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $1.68 Million - $2.07 Million	-21,600 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $1.51 Million - $1.93 Million	21,600	21,600 $1.92 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Peavine Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Peavine Capital, LLC with notifications on news.